AI English summary of an SEC filing — figures as filed
Humana HUMThe company said the Centers for Medicare and Medicaid Services (CMS) issued its preliminary 2025 Medicare Advantage and Part D payment rates and proposed policy changes (the Advance Notice) on Wednesday, January January 31, 2024, after the stock market closed, and that the final rates (the Final Notice) will be published on April 1, 2024.
Key points
AI summaryThe company said the Centers for Medicare and Medicaid Services (CMS) issued its preliminary 2025 Medicare Advantage and Part D payment rates and proposed policy changes (the Advance Notice) on Wednesday, January January 31, 2024, after the stock market closed, and that the final rates (the Final Notice) will be published on April 1, 2024.
The company said CMS estimates that, based on the proposals in the Advance Notice, Medicare Advantage plans across the sector will see benchmark funding fall by an average of 0.16%. The company said the estimate excludes the impact of fee-for-service county rebasing/re-pricing.
The company said its preliminary analysis indicates the proposals in the Advance Notice would result in a change to its benchmark funding that is approximately 160 basis points worse than its expectation of a flat rate environment. The company cited the proposed effective growth rate restatements and CMS’ negative normalization factors as the main drivers of the difference.
The company said its 2025 Adjusted Earnings Per Share (EPS) growth outlook of $6 to $10 is unchanged because the Advance Notice is preliminary. It said it plans to provide CMS with actuarial data and formal commentary.
Summary
AI-writtenAnalysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
CMS 2025 Advance Notice Released and Final Notice Timing
The company said the Centers for Medicare and Medicaid Services (CMS) issued its preliminary 2025 Medicare Advantage and Part D payment rates and proposed policy changes (the Advance Notice) on Wednesday, January January 31, 2024, after the stock market closed, and that the final rates (the Final Notice) will be published on April 1, 2024.
Source · Based on the filing body and exhibits
CMS Estimates 0.16% Decline in Industry Benchmark Funding
The company said CMS estimates that, based on the proposals in the Advance Notice, Medicare Advantage plans across the sector will see benchmark funding fall by an average of 0.16%. The company said the estimate excludes the impact of fee-for-service county rebasing/re-pricing.
Source · Based on the filing body and exhibits
Humana’s Own Analysis: About 160 basis points Worse Than Flat Rate Environment
The company said its preliminary analysis indicates the proposals in the Advance Notice would result in a change to its benchmark funding that is approximately 160 basis points worse than its expectation of a flat rate environment. The company cited the proposed effective growth rate restatements and CMS’ negative normalization factors as the main drivers of the difference.
Source · Based on the filing body and exhibits
Adjusted EPS Growth Outlook Maintained for 2025 and CMS Response Plans
The company said its 2025 Adjusted Earnings Per Share (EPS) growth outlook of $6 to $10 is unchanged because the Advance Notice is preliminary. It said it plans to provide CMS with actuarial data and formal commentary.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…